Emilie Mamessier
13PUBLICATIONS
73CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Oct 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.Marc Lopez, Emerence Crompot, Emmanuelle Josselin
|Mar 29, 2023
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype.Alexandre de Nonneville, Pascal Finetti, Laurys Boudin
|Jan 21, 2023
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma.David Jeremie Birnbaum, Maelle Picard, Quentin Da Costa
|Nov 03, 2022
First-in-Human, Phase I Study of PCA062 in Solid Tumors-Letter.Bernadette de Rauglaudre, Pascal Finetti, David Jérémie Birnbaum
|Oct 25, 2022
Loss of primary cilia promotes inflammation and carcinogenesis.Conception Paul, Ruizhi Tang, Ciro Longobardi
|Jul 27, 2022
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression.Laurys Boudin, Alexandre De Nonneville, Pascal Finetti
Pageof 3
Frequent Collaborators
11 joint publications
François Bertucci
9 joint publications
Pascal Finetti
3 joint publications
Marc Lopez
3 joint publications
Alexandre de Nonneville
3 joint publications
Max Chaffanet
3 joint publications
Arnaud Guille
3 joint publications
Anthony Goncalves
3 joint publications
Quentin Da Costa
2 joint publications
Claire Acquaviva
2 joint publications
Anne Farina
